Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients without ASCVD: The VICTORION-Mono Randomized Clinical Trial

Journal:

Journal of the American College of Cardiology

Published:

2025-05-06

DOI:

10.1016/j.jacc.2025.04.049

Affiliations:

7

Authors:

11

Go to article

Institutions	Authors	Share
Novartis Pharmaceuticals Corporation, United States of America (USA)	3.000000	0.27
Novartis, Switzerland	3.000000	0.27
Las Palmas Medical Research Center, United States of America (USA)	1.000000	0.09
CardioLink ClinTrials S.C., Mexico	1.000000	0.09
University of California, San Diego (UC San Diego), United States of America (USA)	1.000000	0.09
Mayo Clinic, United States of America (USA)	1.000000	0.09
Dothan Medical Associates, P.C., United States of America (USA)	1.000000	0.09

Interested in Cardiovascular Medicine and Haematology?